Important notice regarding Inveltys

Posted in Latest News on August 7, 2019.

Important notice regarding Inveltys:

The board approved Inveltys (loteprednol etabonate ophthalmic suspension) 1% for addition to Rule 64B13-18.002. Effective August 5, 2019, Licensees are now permitted to prescribe Inveltys.



More Latest News

Nonopioid Alternatives Pamphlet
July 1, 2020

2020 legislation amended the requirements for non-opioid alternatives. Click here to access the pamphlet for “Information on Nonopioid Alternatives for the Treatment of Pain” Continue reading →


New Legislation Impacting Your Profession
June 12, 2020

Click here to view a full list of bill summaries from the 2020 Florida Legislative Session that may impact your profession. Continue reading →